药品注册申请号:065332
申请类型:ANDA (仿制药申请)
申请人:TEVA PHARMS
申请人全名:TEVA PHARMACEUTICALS USA
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CEFDINIR CEFDINIR FOR SUSPENSION;ORAL 125MG/5ML No No AB 2007/05/04 2007/05/04 Prescription
002 CEFDINIR CEFDINIR FOR SUSPENSION;ORAL 250MG/5ML No No AB 2007/05/04 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2023/06/06 SUPPL-17(补充) Approval Labeling STANDARD
2020/03/09 SUPPL-16(补充) Approval Labeling STANDARD
2020/03/09 SUPPL-14(补充) Approval Labeling STANDARD
2009/08/27 SUPPL-9(补充) Approval Labeling
2008/10/17 SUPPL-8(补充) Approval Labeling
2008/06/12 SUPPL-6(补充) Approval Labeling
2008/03/07 SUPPL-5(补充) Approval Labeling
2007/05/04 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:CEFDINIR 剂型/给药途径:FOR SUSPENSION;ORAL 规格:125MG/5ML 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
065259 001 ANDA CEFDINIR CEFDINIR FOR SUSPENSION;ORAL 125MG/5ML Prescription No No AB 2006/05/31 LUPIN
065337 001 ANDA CEFDINIR CEFDINIR FOR SUSPENSION;ORAL 125MG/5ML Prescription No No AB 2007/04/06 CHARTWELL RX
065332 001 ANDA CEFDINIR CEFDINIR FOR SUSPENSION;ORAL 125MG/5ML Prescription No No AB 2007/05/04 TEVA PHARMS
065429 001 ANDA CEFDINIR CEFDINIR FOR SUSPENSION;ORAL 125MG/5ML Prescription No No AB 2007/07/18 ANDA REPOSITORY
065473 001 ANDA CEFDINIR CEFDINIR FOR SUSPENSION;ORAL 125MG/5ML Prescription No No AB 2007/12/14 AUROBINDO PHARMA
210534 001 ANDA CEFDINIR CEFDINIR FOR SUSPENSION;ORAL 125MG/5ML Prescription No No AB 2021/02/19 ALKEM LABS LTD
活性成分:CEFDINIR 剂型/给药途径:FOR SUSPENSION;ORAL 规格:250MG/5ML 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
065337 002 ANDA CEFDINIR CEFDINIR FOR SUSPENSION;ORAL 250MG/5ML Prescription No No AB 2007/04/06 CHARTWELL RX
065332 002 ANDA CEFDINIR CEFDINIR FOR SUSPENSION;ORAL 250MG/5ML Prescription No No AB 2007/05/04 TEVA PHARMS
065259 002 ANDA CEFDINIR CEFDINIR FOR SUSPENSION;ORAL 250MG/5ML Prescription No No AB 2007/05/07 LUPIN
065429 002 ANDA CEFDINIR CEFDINIR FOR SUSPENSION;ORAL 250MG/5ML Prescription No No AB 2007/07/18 ANDA REPOSITORY
065473 002 ANDA CEFDINIR CEFDINIR FOR SUSPENSION;ORAL 250MG/5ML Prescription No Yes AB 2007/12/14 AUROBINDO PHARMA
210534 002 ANDA CEFDINIR CEFDINIR FOR SUSPENSION;ORAL 250MG/5ML Prescription No No AB 2021/02/19 ALKEM LABS LTD
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database